Clinical Stage Drug Development Company
Projecting Phase 2 Data – Q2, 2022 for Idiopathic Pulmonary Fibrosis & Chronic Cough Study
Lead Program Includes Investigating the Psychedelic Drug DMT for Stroke
Clinical Stage Drug Development Company
Projecting Phase 2 Data – Q2, 2022 for Idiopathic Pulmonary Fibrosis & Chronic Cough Study
Lead Program Includes Investigating the Psychedelic Drug DMT for Stroke